Welcome to TB CARE II

TB CARE II is a five-year project from the United States Agency for International Development designed to provide global leadership and assist National Tuberculosis Programs in high burden countries around the world to accelerate the implementation of programs for TB DOTS, TB/HIV and Programmatic Management of Drug Resistant TB (PMDT). Led by University Research Co., LLC (URC), the TB CARE II Project team is comprised of leading organizations involved in building TB service delivery systems worldwide, including Partners in Health, Jhpiego, Project HOPE, and many others. TB CARE II programs work with a wide segment of stakeholders, including policy planners, public sector providers, communities, and patients to scale up evidence-based interventions and improve outcomes in tuberculosis prevention and control.

Reducing Delays in TB Diagnosis: Data Collection Tools to evaluate the cause and frequency of TB delays

 Understanding and identifying the causes of delays in diagnosis and treatment initiation are critical to strengthening TB control programs overall. Passive case finding approaches which are prevalent in many TB programs perpetuate delays by failing both to ensure that the health system regularly captures TB suspects and also by failing to engage the population in understanding their own TB risk, and to build awareness of when and where to seek out TB services. Read more »

TB CARE II staff work with vulnerable MDR TB patients in Malawi

Read a story about Zefa, a Malawian woman with MDR TB who gained access to treatment through TB CARE II

A difficult disease under challenging circumstances

TB CARE II Bangladesh Participates in America Week

Sponsored by U.S. Embassy, Dhaka, America Week was a three-day event from January 30 to February 1, 2012, organized in Chittagong, the second largest and the port city of Bangladesh. “Moving Forward Together” was the theme of the Week that showcased U.S. Embassy including USAID supported activities in Bangladesh. The U.S. Ambassador to Bangladesh, Mr. Dan Mozena, and Mayor of Chittagong City Corporation Mr. Manjur Alam inaugurated the event.
 

TB CARE II addresses the need for stronger TB services for expectant mothers

In 2009 there were an estimated 9.4 million incident cases of TB, yet only 5.8 million cases were notified, providing evidence of the need for improved case finding as a first step to decreasing the global burden of this airborne disease. TB is the leading cause of death for people living with HIV globally and over 60 percent of people living with HIV in Africa are women. New strategies to address TB/HIV co-infection in adults and children are urgently needed, particularly in high burden countries. HIV/AIDS contributed to 9% of all maternal deat

TB CARE II introduces new manual: "Community-Based Care for drug-Resistant TB – A Guide for Implementers"

Report cover page

Many countries are in the process of establishing or scaling up treatment of drug-resistant tuberculosis (DR TB). Effectively scaling up treatment will require addressing health systems–related issues, such as task shifting to alleviate human resources shortages and greater community engagement.
A principal challenge in establishing or scaling up treatment of DR TB is deciding what model of care to implement. A crucial step is bridging the gap between the hospital and the community to ensure continuity of care. For DR TB treatment to be truly patient-centered, patients must be supported in their homes and communities.
The USAID TB CARE II project, with support from Partners In Health, collaborated with Ministries of Health and National TB Program managers in Southern, West, and Central Africa, along with NGOs and other TB stakeholders to develop this guide on introducing and managing programs for community-based DR TB care. This guide provides practical, step-by-step guidance on how to organize, implement, and monitor community based care for DR TB. It is equally useful for program planning or supervision. The target audience for this guide is TB Program Managers, governments, policy makers, nongovernmental organizations (NGOs), donors and TB advocates.